Beschreibung
Provides an update on current treatment and recent trials concerning progressive multiple sclerosis (MS)Guides physicians who manage patients with progressive MSReviews current theories concerning pathophysiological mechanisms of progressive MS disease progression Relates basic research to potential therapies in progressive MS
Autorenporträt
Dr Alastair Wilkins (BA, MB,BChir, PhD(Cantab)) is Reader in Neurology, University of Bristol, and Consultant Neurologist at Southmead Hospital, Bristol, UK. He researches axonal injury in multiple sclerosis and related disorders.
Herstellerkennzeichnung:
Springer Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE
E-Mail: juergen.hartmann@springer.com




































































































